Mining Press Releases
SEE OTHER BRANDS

Keeping up with mining news from the world

Mining Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.

Press releases published on August 11, 2025

Life360 Reports Record Q2 2025 Results

Life360 Reports Record Q2 2025 Results

Monthly Active Users Reached Approximately 88.0 million; Up 25% Year-Over-Year Record Q2 Global Net Additions of 136 thousand Paying Circles, Reaching 2.5 million Total Total Quarterly Revenue Increased 36% Year-Over-Year to $115.4 million Annualized …

Heidmar Maritime Holdings Corp. Reports Second Quarter 2025 Results

Heidmar Maritime Holdings Corp. Reports Second Quarter 2025 Results

ATHENS, Greece and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR) today reported its results for the quarter and six month period ended June 30, 2025. Second Quarter 2025 Highlights …

FutureFuel Releases Second Quarter 2025 Results

FutureFuel Releases Second Quarter 2025 Results

CLAYTON, Mo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarter ended June 30, 2025. Second quarter 2025  …

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap® for commercialized vaccine …

PubMatic Announces Second Quarter 2025 Financial Results

PubMatic Announces Second Quarter 2025 Financial Results

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 34% year-over-year and was 41% of total revenue; CTV revenue grew over 50% year-over-year; Supply Path Optimization represented 55%+ of total …

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …

Globus Maritime Announces Annual Meeting of Shareholders

Globus Maritime Announces Annual Meeting of Shareholders

GLYFADA, Greece, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that the annual meeting of shareholders will be held at the offices of Globus Shipmanagement …

VirTra Reports Second Quarter and Six Months 2025 Financial Results

VirTra Reports Second Quarter and Six Months 2025 Financial Results

Second Quarter Revenue Increases 15% Year-Over-Year; Six-Month Revenue Up 5% Delivers Continued Positive Net Income and Strong Gross Margins as Federal Funding Trends Improve CHANDLER, Ariz., Aug. 11, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“ …

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in June NASHVILLE, …

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2025

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2025

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 31, 2025, short interest in 3,285 Nasdaq Global MarketSM securities totaled 13,683,072,188 shares compared with 13,792,841,090 shares in 3,260 Global Market issues …

Metagenomi Appoints Laurence Reid, PhD to its Board of Directors

Metagenomi Appoints Laurence Reid, PhD to its Board of Directors

EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today …

Main Street Financial Services, Corp. Announces Opening of Full-Service Branch in St. Clairsville, Ohio

Main Street Financial Services, Corp. Announces Opening of Full-Service Branch in St. Clairsville, Ohio

WOOSTER, Ohio, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Main Street Financial Services, Corp. (OTCQX: MSWV), the holding company for Main Street Bank, is pleased to announce the opening of a full-service branch in St. Clairsville, Ohio. The new location, situated …

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

WILMINGTON, Del., Aug. 11, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its second quarter 2025 financial results …

Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Type A meeting with U.S. FDA scheduled to discuss Deramiocel BLA and path toward potential approval Capricor seeks to resubmit its BLA based on its existing dataset, with HOPE-3 data (expected in Q4 2025) potentially serving as supportive and confirmatory …

Life360 Names COO Lauren Antonoff as Chief Executive Officer

Life360 Names COO Lauren Antonoff as Chief Executive Officer

Co-Founder Chris Hulls will serve as Executive Chairman of the Board Planned leadership succession signals continued investment in product innovation and growth SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Life360 (Nasdaq: LIF), the category-defining …

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates

Presented positive 6-month clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, while continuing to function and persist with stable C- …

ACV Announces Second Quarter 2025 Results

ACV Announces Second Quarter 2025 Results

Second quarter revenue of $194 million Second quarter GAAP net income (loss) of ($7) million Second quarter non-GAAP net income of $12 million Second quarter Adjusted EBITDA of $19 million Expects 2025 revenue of $765 million to $775 million, growth of 20% …

Synchronoss Technologies Reports Second Quarter 2025 Results

Synchronoss Technologies Reports Second Quarter 2025 Results

Second Quarter Revenue of $42.5 Million, Including 92.6% Recurring Revenue Received CARES Act Tax Refund in Full, Amounting to $33.9 Million Reaffirms All Full Year Guidance Metrics BRIDGEWATER, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Synchronoss …

Assertio Reports Second Quarter 2025 Financial Results

Assertio Reports Second Quarter 2025 Financial Results

Second Quarter Total Net Product Sales of $28.8 Million, Cash and Investments Increase to $98.2 Million Narrows Guidance on Continued Progress Implementing Long-Term Business Strategy LAKE FOREST, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, …

BioVie Inc. Announces Closing of $12 Million Public Offering

BioVie Inc. Announces Closing of $12 Million Public Offering

CARSON CITY, Nev., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions